Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Neoplastic Cells, Circulating, Oropharyngeal Neoplasms

NCT02997709 2026-03-04

COMBINE

Recruiting

144 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT06678724 2026-02-24

Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

Recruiting

30 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplastic Cells, Circulating

NCT07418125 2026-02-18

GALIA

Phase NA Recruiting

130 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT07396259 2026-02-09

Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

Recruiting

150 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplastic Cells, Circulating

NCT07398170 2026-02-09

BIOLIMEN-1

Phase NA Not yet recruiting

15 enrolled

CNS

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

NCT02072616 2026-02-06

CTC-Pancreas

Phase NA Completed

101 enrolled

Neoplastic Cells, Circulating

NCT05360290 2026-02-03

CTCNeoBC-E

Phase NA Recruiting

484 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT05988970 2026-01-27

SLEEP_CTC

Phase NA Completed

27 enrolled

Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating

NCT05560776 2026-01-26

OPTIMAL

Phase NA Active not recruiting

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplastic Cells, Circulating

NCT05247164 2026-01-15

EUPhORIC

Phase NA Active not recruiting

70 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT07329920 2026-01-12

Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadjuvant/Conversion Therapy

Completed

300 enrolled

Neoplastic Cells, Circulating

Clinical Trials

CTCO

COMBINE

Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

GALIA

Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

BIOLIMEN-1

CTC-Pancreas

CTCNeoBC-E

SLEEP_CTC

OPTIMAL

EUPhORIC

Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadjuvant/Conversion Therapy